Stock detail

Illumina (ILMN) stock price, chart, and key data

View Illumina stock price, chart movement, and headline metrics on Woodstock's stock detail page.

ILMN

Stock detail

Illumina

ILMN · XNAS

-$14.41 (-7.54%) past day

$176.61

Overnight $178.00 (+0.79%)

XNAS24/5 tradingLast updated: Jul 25, 01:01 PM

Key metrics

Financials

Quarterly revenue, profitability, and balance-sheet snapshot

2.171.631.080.540.00
FY2025 Q2Reported Revenue: $1BExpected Revenue: $1BNet income: $235MReported EPS: 1.49Expected EPS: 1.19
FY2025 Q3Reported Revenue: $1BExpected Revenue: $1BNet income: $150MReported EPS: 0.98Expected EPS: 1.34
FY2025 Q4Reported Revenue: $1BExpected Revenue: $1BNet income: $334MReported EPS: 2.17Expected EPS: 1.35
FY2026 Q1Reported Revenue: $1BExpected Revenue: $1BNet income: $134MReported EPS: 0.87Expected EPS: 1.15
FY2026 Q2Expected Revenue: $1B
FY2026 Q3Expected Revenue: $1B
1.2B927.2M695.4M463.6M231.8M0
FY25 Q2Q3Q4FY26 Q1Q2Q3

Operating income & Operating cash flow

Quarterly revenue, profitability, and balance-sheet snapshot

364M291.2M218.4M145.6M72.8M0
FY2024 Q4Operating income: $251MOperating cash flow: $364M
FY2025 Q1Operating income: $184MOperating cash flow: $240M
FY2025 Q2Operating income: $224MOperating cash flow: $234M
FY2025 Q3Operating income: $232MOperating cash flow: $284M
FY2025 Q4Operating income: $228MOperating cash flow: $321M
FY2026 Q1Operating income: $200MOperating cash flow: $289M
FY24 Q4FY25 Q1Q2Q3Q4FY26 Q1

Total assets & Total liabilities

Quarterly revenue, profitability, and balance-sheet snapshot

6.6B5.3B4B2.7B1.3B0
FY2024 Q4Total assets: $6BTotal liabilities: $4B
FY2025 Q1Total assets: $6BTotal liabilities: $4B
FY2025 Q2Total assets: $6BTotal liabilities: $4B
FY2025 Q3Total assets: $6BTotal liabilities: $4B
FY2025 Q4Total assets: $7BTotal liabilities: $4B
FY2026 Q1Total assets: $7BTotal liabilities: $4B
FY24 Q4FY25 Q1Q2Q3Q4FY26 Q1

Total equity & Shares outstanding

Quarterly revenue, profitability, and balance-sheet snapshot

2.7B2.2B1.6B1.1B544.6M0
FY2024 Q4Total equity: $2BShares outstanding: 158.4M
FY2025 Q1Total equity: $2BShares outstanding: 158.3M
FY2025 Q2Total equity: $2BShares outstanding: 153.7M
FY2025 Q3Total equity: $2BShares outstanding: 152.8M
FY2025 Q4Total equity: $3BShares outstanding: 152.9M
FY2026 Q1Total equity: $3BShares outstanding: 151.3M
FY24 Q4FY25 Q1Q2Q3Q4FY26 Q1

Day range

$189.42 - $198.09

52-week range

$88.00 - $196.66

Close price

$196.86

Market cap

$29.8B

P/E ratio

203

Beta

1.47

Financials

FY2026 Q1

Operating income

$200M

Operating cash flow

$289M

EPS

0.87

Shares outstanding

151.3M

Total assets

$7B

Total equity

$3B

Total liabilities

$4B

About the company

Illumina Inc

Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries. Illumina's customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies.

Analyst rating summary

A current read on analyst sentiment from the insight feed.

Mean target

$169

Current price $194
Low$95.00High$210

8

Buy

/ 15

Recent calls

07/17/2026

Leerink Partners

Puneet Souda

Buy · Price target $210

07/15/2026

TD Cowen

Daniel Brennan

Hold · Price target $192

07/13/2026

Canaccord Genuity

Kyle Mikson CFA

Hold · Price target $190

Ticker holders

Review politician disclosures and insider transactions in tabs.

Holder directory

Select a heading to reorder by name, activity date, buy/sell, or displayed value.

7/7

#1Michael Burgess

republican · House · TX-26

spouse
  • Sell$15,001 / $32,501 / $50,000
$15,001/$32,501/$50,000

#2Michael Burgess

republican · House · TX-26

self
  • Sell$15,001 / $32,501 / $50,000
$15,001/$32,501/$50,000

#3Ro Khanna

democrat · House · CA-17

child
  • Sell$1,000 / $8,000 / $15,000
$1,000/$8,000/$15,000

#4Gilbert Cisneros

democrat · House · CA-31

self
  • Buy$1,001 / $8,001 / $15,000
310/120/499

#5Thomas Kean

republican · House · NJ-7

self
  • Buy$1,001 / $8,001 / $15,000
  • Buy$1,001 / $8,001 / $15,000
263/32/494

#6Donald J Trump

republican · Executive

self
2026
43/5/81

#7Lisa McClain

republican · House · MI-9

spouse
  • Sell$1,001 / $8,001 / $15,000
  • Buy$1,001 / $8,001 / $15,000
  • Sell$1,001 / $8,001 / $15,000
  • Buy$1,001 / $8,001 / $15,000
29/3/55

Market action

A concise summary of the latest filing, transaction, or market-moving item.

Illumina, Inc. director Keith A. Meister reported an ownership change in Illumina common stock tied to his board compensation for the second quarter of 2026. The Form 4 reports that on June 30, 2026, Meister received Illumina common stock in lieu of cash retainer fees. According to the explanatory note, Meister had elected to receive 100% of his 2026 board and committee cash retainer fees in Illumina stock. The shares reported in this filing represent his second-quarter 2026 retainer fees. Illumina calculates the number of shares issued by dividing the cash compensation otherwise payable for the just-completed quarter by the volume-weighted average closing price of Illumina shares over that quarter, based on each trading day during the period. The filing text provided does not show the exact number of shares issued, the transaction price, the transaction code, or Meister’s total beneficial ownership after the transaction. The filing also notes that certain Illumina securities are held for the accounts of private investment funds collectively referred to as the “Corvex Funds,” for which Corvex Management LP serves as investment adviser. These include Corvex Master Fund LP and Corvex Select Equity Master Fund LP. Meister is treated as having an indirect beneficial interest because the general partner of Corvex is controlled by him. The report was signed on Meister’s behalf by Robert Maynes on July 2, 2026. The action reflects compensation-related stock issuance to a director rather than an open-market purchase or sale.

24/5 Trading

Act on the stock when the timing works for you.

With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.

*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.

Download the app
24/5 trading chart preview

Sign Up

Scan the QR code to get started

Contact via LINE

Scan the QR code to get started

LINE QR Code